glp-1 7-37 PDB-101: Diabetes Mellitus: Diabetes Mellitus: undefined: Incretins GLP - Glucagon Like Peptides

Description

Same-day virtual appointments and physician-guided GLP-1 weight-loss care from home.

However, the incidence of CRC was not significantly associated with GLP-1 RA use compared with other drugs (OR, 1.73

What does evidence say about GLP-1 agonists and suicidal ideation

A bariatric surgeon compares Saxenda, Wegovy, Ozempic and Zepbound, explaining how doctors decide which GLP-1 weight loss medication is best for each patient.

What they found was cost dominates treatment decisions: 68% said cost influenced their decision to start or continue treatment 44% said the medication cost more than they expected Cost surpassed side effects as the #1 reason people stopped taking GLP-1s A breakdown of the financial burden: 24% pay more than $250 per prescription fill Nearly 8% pay $500 or more per fill 24% said insurance didn't cover any cost Weight management patients were nearly twice as likely to pay $250+ vs diabetes patients --- Here's what patients are thinking: Nearly 40% ended up using discount programs or manufacturer coupons 60% know someone who wants GLP-1s but can't afford them 83% believe Americans turn to DTC programs because traditional healthcare is too expensive Patients still prioritize safety: 60% are aware of safety risks with non-FDA-approved GLP-1s--this one surprised me